2026 School of Medicine Leadership Retreat

Mission Bay, Genentech Hall, Byers Auditorium, 600 16th Street
3:00 pm - 7:00 pm

Mission Bay, William J. Rutter Center, 1675 Owens Street
8:30 am - 5:00 pm

Distinguished higher education leader James B. Milliken became University of California’s 22nd president on August 1, 2025. 

President Milliken oversees UC’s world-renowned system of 10 campuses, six academic health centers, three affiliated national laboratories, more than 290,000 students and 230,000 faculty and staff. 

President Milliken has more than 30 years of experience serving in leadership roles at large institutions. Most recently, he served as chancellor of the University of Texas System (UT) from 2018-2025, where he also held the Lee Hage and Joseph D. Jamail Regents Chair in Higher Education Leadership.  

As UT’s chancellor, he led one of the largest public university systems in the United States, composed of 14 academic and health institutions, including seven medical schools and five Carnegie R1 research universities.   He led efforts to meet the needs of a growing and diversifying state and nation, including a commitment to increasing training, education, and research programs in information technology, cybersecurity, advanced manufacturing, public health, and medicine.  

Kirsten Bibbins-Domingo, PhD, MD, MAS is 17th Editor-in-Chief of the Journal for the American Medical Association. She is the Lee Goldman, MD Professor of Medicine and Professor of Epidemiology and Biostatistics at the University of California, San Francisco. She previously served as the Chair of the Department of Epidemiology and Biostatistics and as the inaugural Vice Dean for Population Health and Health Equity in the UCSF School of Medicine. She co-founded the UCSF Center for Vulnerable Populations at Zuckerberg San Francisco General Hospital that focuses on actionable research to improve health equity and reduce health disparities. 

Dr. Bibbins-Domingo is a general internist and cardiovascular epidemiologist whose scholarship includes observational epidemiology, pragmatic trials, and simulation modeling to examine clinical and public health approaches to prevention in the US and globally. She previously served on and led the US Preventive Services Task Force from 2010-2017. She has received numerous honors, including induction into the American Society for Clinical Investigation, the National Academy of Medicine, and the American Academy of Arts and Sciences. 

Andrew Bindman, MD, is executive vice president and chief medical officer for Kaiser Permanente. He is responsible for driving superior quality and equitable health outcomes through the integration of quality innovation, care delivery, data analytics, and research in collaboration with the Permanente Medical Groups. He is also Kaiser Permanente’s executive sponsor for the Kaiser Permanente Bernard J. Tyson School of Medicine.

Prior to joining Kaiser Permanente, Dr. Bindman spent more than 30 years on the faculty at the University of California, San Francisco where he practiced and taught internal medicine while conducting research on health access and outcomes that resulted in more than 200 published scientific articles.  He also served as the Director of the Agency for Healthcare Research and Quality in 2016-2017.

Dr. Bindman is a graduate of Harvard College and the Mount Sinai School of Medicine. A board-certified general internist, he completed his residency in internal medicine at UCSF and was a Robert Wood Johnson Foundation Clinical Scholar at Stanford University. He is an elected member of the National Academy of Medicine and the Association of American Physicians.

Eliseo J. Pérez-Stable, M.D. was Director of the National Institute on Minority Health and Health Disparities (NIMHD) at the National Institutes of Health (NIH) from September 1, 2015, to April 1, 2025. On September 30, 2025, Dr. Pérez-Stable retired from federal service. During the time as NIMHD Director, he oversaw an annual budget of $535 million to advance the science of minority health and health disparities research. NIMHD conducts and supports research programs to advance knowledge and understanding of health disparities, identify mechanisms to improve minority health and reduce health disparities, and develop effective interventions to reduce health disparities in community and clinical settings. During his tenure at NIMHD, Dr. Pérez-Stable cultivated the Institute’s position on the cutting edge of the science of minority health and health disparities. Through this effort, NIMHD produced a collection of resources that guide and facilitate the conduct of research to decrease health disparities. Throughout the COVID-19 pandemic, Dr. Pérez-Stable positioned NIMHD at the forefront of the research response to COVID-19 health disparities by co-chairing three major NIH-wide research programs and collaborating with other NIH institutes and centers. In October 2021, Dr. Pérez-Stable was awarded a Samuel J. Heyman Service to America Medal (Sammies) with Gary Gibbons, MD, Director of the National Heart, Lung and Blood Institute.  They received the COVID-19 Response Medal for their extraordinary role in fighting the pandemic in communities of color.

Dr. Pérez-Stable was a professor of medicine and chief of the Division of General Internal Medicine, at the University of California, San Francisco (UCSF) from 1983 to 2015. Dr. Pérez-Stable’s research interests have centered on improving the health of racial and/or ethnic minorities through effective prevention interventions, understanding underlying causes of health disparities, and advancing patient-centered care for underserved populations. Dr. Pérez-Stable spent 32 years leading research on smoking cessation and tobacco control in Latino populations in the United States and Latin America, addressing clinical and prevention issues in cancer control research, supporting early career scientists in research on minority aging in clinical and community settings, and addressing research questions in clinical conditions such as hypertension, asthma, diabetes and dementia.  Dr. Pérez-Stable maintained a research laboratory at NIH as a Senior Investigator with tenure in the Intramural Research Program until he was fired by the NIH Director and HHS Secretary. He has published more than 350 peer-reviewed papers and was continuously funded by NIH grants for 30 years prior to becoming NIMHD Director. Dr. Pérez-Stable was elected to the National Academy of Medicine (formerly Institute of Medicine) of the National Academy of Science in 2001. He earned his B.A. in chemistry in 1974 and M.D. in 1978 from the University of Miami. He then completed his primary care internal medicine residency and a research fellowship in general internal medicine at UCSF before joining the faculty as an assistant professor in 1983. Dr. Pérez-Stable practiced primary care internal medicine for 37 years at UCSF following a panel of about 200 patients and supervised and taught students and residents in the ambulatory care and hospital settings.

Lindsey A. Criswell, M.D., M.P.H., D.Sc., is a rheumatologist and human genetic epidemiologist who has played a major role in the identification of genes and environmental factors that contribute to risk and outcome of autoimmune rheumatic diseases. Dr. Criswell has substantial training and experience in epidemiologic and statistical methods for identifying genes that contribute to complex human disorders. Dr. Criswell’s contributions to genome-wide association studies (GWAS) of systemic erythematosus (SLE), rheumatoid arthritis (RA), and Sjögren’s disease resulted in the identification of many genes that contribute to these disorders. In addition to leading projects that seek to refine genotype-phenotype associations for specific manifestations of autoimmune diseases, Dr. Criswell also leads studies that seek to determine whether epigenetic factors, such as differences in DNA methylation status, contribute to risk and outcome of SLE, RA and Sjögren’s disease. 

With 20 years’ experience recruiting and enrolling autoimmune disease patients for participation in genetic and epidemiologic studies, Dr. Criswell played a major role in the development of several national and international consortia. As vice chancellor for research at the University of California, San Francisco (UCSF), she was responsible for directing UCSF’s effort to advance innovative, collaborative, and interdisciplinary biomedical research across the university’s professional schools and graduate programs. Dr. Criswell also served as the program director for theNational Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS) P30 Precision Medicine in Rheumatology (PREMIER) Center and was co-PI for the Clinical and Translational Science Institute at UCSF. Currently, Dr. Criswell serves as the director of the National Institute of Arthritis and Musculoskeletal and Skin Diseases (NIAMS), and head of the Genomics of Autoimmune Rheumatic Disease Section at the National Human Genome Research Institute (NHGRI). Dr. Criswell is deeply committed to mentoring at all levels and has personally mentored more than 50 predoctoral, doctoral, and postdoctoral trainees. She has also been elected to theAssociation of American Physicians and the National Academy of Medicine.  

Elena Fuentes-Afflick, MD, MPH, is the Association of American Medical Colleges’ (AAMC) Chief Scientific Officer and leads the association’s programs that support medical research and the training of physician-scientists and researchers in academic medicine. She provides leadership and vision for addressing research and science policy and other related critical issues facing academic medicine, medical schools, teaching health systems, and teaching hospitals. 

Before joining the AAMC, Dr. Fuentes-Afflick served as professor of pediatrics at the University of California, San Francisco (UCSF) and vice dean for the UCSF School of Medicine at Zuckerberg San Francisco General (ZSFG) Hospital. She previously served as chief of pediatrics at ZSFG and vice dean for academic affairs for the UCSF School of Medicine.

An elected member of the National Academy of Medicine and the American Academy of Arts and Sciences, Dr. Fuentes-Afflick’s scholarly work has focused on Latino health, acculturation, immigrant health, health disparities, faculty misconduct, and diversity in academic medicine. Dr. Fuentes-Afflick has served in national leadership roles for the Society for Pediatric Research, the American Pediatric Society, and the National Academy of Medicine. In 2023, she received the Joseph W. St. Geme, Jr. Leadership Award from the Federation of Pediatric Organizations for sustained, impactful contributions to child health.

Dr. Fuentes-Afflick earned her undergraduate and medical degrees at the University of Michigan and a master’s degree in public health from the University of California, Berkeley. She completed her pediatric residency and chief residency at UCSF, followed by a research fellowship at the UCSF Philip R. Lee Institute for Health Policy Studies.

Kelsey Martin, MD, PhD is Executive Vice President of the Simons Foundation Autism and Neuroscience programs. In this role, she supports large-scale basic, translational, and clinical neuroscience research around the globe. She is also a Professor Emeritus on Active Recall in the Department of Biological Chemistry at UCLA, where her research lab studies the molecular and cell biology of long-term memory, with a focus on how experience alters connectivity between neurons. Her laboratory has pioneered studies on the regulation of gene expression within neurons during long-term memory formation, highlighting a critical role for signaling between the synapse and nucleus and for local regulation of protein synthesis at the synapse. Deeply committed to academic medicine, Dr. Martin served as Dean of the David Geffen School of Medicine at UCLA from 2015-2021. As Dean, she established programs in precision health and computational medicine, founded a master’s program in genetic counseling, and developed a series of interdepartmental research initiatives spanning basic through clinical research. After receiving a BA in English from Harvard, Dr. Martin was a public health Peace Corps volunteer in the Democratic Republic of Congo. She then pursued MD/PhD training at Yale University, receiving her MD and her PhD in Molecular Biophysics and Biochemistry in 1992. She undertook postdoctoral training in neurobiology with Nobel Laureate Eric Kandel at Columbia University and joined the UCLA faculty in 1999. Among her service roles, Dr. Martin is President of the Board of Directors of the McKnight Endowment Fund for Neuroscience and is a member of the Board of Directors of the W. M. Keck Foundation, National Academy of Medicine Council and HHMI Scientific Review Board. She was elected to the American Academy of Arts and Sciences and the National Academy of Medicine in 2016, and to the National Academy of Sciences in 2024. 

Eric Anthony is Vice President of Government Relations for UCSF Health. He leads the development and execution of government and community relations strategies, activities, and programs to advance UCSF Health priorities. Previously, Anthony served as UCSF’s Senior Director of Federal Government Relations, overseeing the implementation of the University’s federal government relations program and advocacy initiatives, which promoted its strategic policy priorities in biomedical research and clinical care. 

He has over 20 years of experience in politics and policy, spanning political campaigns, government, and nonprofit organizations. He spent nine years working in the House of Representatives for two members of Congress, including senior members of the House Appropriations Committee. Before joining UCSF, he led the policy and regulatory strategy for the International Society for Stem Cell Research.  

Harold R. Collard, MD, MS, is the vice chancellor for Research at UCSF. In this role, Collard oversees and stewards UCSF’s research mission.

Collard is professor of Medicine and Health Policy in the Division of Pulmonary, Critical Care, Allergy and Sleep, Department of Medicine, School of Medicine. A board-certified pulmonologist, he joined UCSF’s faculty in 2005 and served for 12 years as director of the Interstitial Lung Disease Program. Collard is an internationally recognized leader in the care and research of patients with interstitial lung disease. He has over 200 peer-reviewed research publications and was awarded the 2019 Gold Medal in Interstitial Lung Disease from the European Respiratory Society for his research leadership in the field. Collard also received the 2020 American Thoracic Society Clinical Problems Assembly Mentorship Award in recognition of his central role in developing the next generation of interstitial lung disease research leaders.

Deeply committed to advancing UCSF’s research mission, Collard previously served as associate vice chancellor of Clinical Research and director of UCSF’s Clinical and Translational Science Institute. In this role, he helped to position the University as a leader in the NIH’s national consortium of clinical research institutions and developed programs to support the needs of its clinical trialists and biospecimen-based researchers. During this time, Collard also helped lead the UCSF research community through the early phases of the SARS CoV-2 pandemic, advocating strongly for their needs.

Collard believes the next decade will be a critical period for UCSF’s research community and views the vice chancellor for Research as a crucial champion and steward of the University’s research mission. His priorities for UCSF include ensuring,  enabling, and positioning its research community for success across the spectrum of disciplines and departments; making UCSF a partner of choice for clinical trials; ensuring curiosity-driven science remains a foundational component of research activities; and growing relationships with community partners and policymakers to prioritize and promote health research. Collard also is strongly committed to UCSF PRIDE Values and building a community of trust and opportunity for all.

Collard received his AB cum laude in Biochemical Sciences and Molecular Biology from Harvard College, and his MD from Duke University. He completed internship, residency, and chief residency in Internal Medicine at UCSF and completed a fellowship in Pulmonary and Critical Care Medicine at the University of Colorado. As part of his research training, Collard earned a Certificate in Clinical Science from the University of Colorado and an MS in Health Law and Policy from the UC Hastings College of the Law and UCSF.